Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

CMS Panel To Consider Home Testing For Sleep Apnea

This article was originally published in The Gray Sheet

  • News

Executive Summary

A Medicare advisory panel is set to meet Sept. 12 to consider how well portable home monitors can help diagnose obstructive sleep apnea

You may also be interested in...



CMS Panel Gives Moderate Support To Home-Based Sleep Apnea Tests

A CMS advisory committee expressed moderate support for home sleep testing monitors to help diagnose obstructive sleep apnea Sept. 12

CMS Panel Gives Moderate Support To Home-Based Sleep Apnea Tests

A CMS advisory committee expressed moderate support for home sleep testing monitors to help diagnose obstructive sleep apnea Sept. 12

CMS May Relax Sleep Apnea Testing Requirement For CPAP Coverage

CMS will reconsider how it pays for continuous positive airway pressure (CPAP) therapy, potentially modifying diagnosis requirements to help expand therapy coverage to more patients with sleep apnea

Table

View full table

Tags:
Latest Headlines

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

See All
UsernamePublicRestriction

Register

MT025225

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By